Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue:
Revenue	$ 915	$ 401	$ 2,079	$ 1,267
Expenses:
Cost of product revenues	54	60	98	102
Research and development	8,499	5,029	16,753	8,503
Selling, general and administrative	5,318	2,946	9,729	5,424
Total expenses	13,871	8,035	26,580	14,029
Loss from operations	(12,956)	(7,634)	(24,501)	(12,762)
Other income (expense):
Interest income (expense), net	941	(246)	1,826	(482)
Loss on fair value adjustment of warrant liability		(1,015)	(294)	(1,160)
Loss on debt extinguishment		(682)		(682)
(Loss) gain on fair value of strategic investments	(31)	1,730	(17)	1,510
Total other income (expense)	910	(213)	1,515	(814)
Net loss	$ (12,046)	$ (7,847)	$ (22,986)	$ (13,576)
Net loss per share
Basic (in Dollars per share)	$ (0.35)	$ (0.77)	$ (0.74)	$ (0.74)
Diluted (in Dollars per share)	$ (0.35)	$ (0.77)	$ (0.74)	$ (0.74)
Weighted-average shares used in computing net loss per share, basic (in Shares)	34,613,466	10,138,169	31,228,323	18,446,239
Weighted-average shares used in computing net loss per share, diluted (in Shares)	34,613,466	10,138,169	31,228,323	18,446,239
Comprehensive loss
Net loss	$ (12,046)	$ (7,847)	$ (22,986)	$ (13,576)
Unrealized loss on marketable securities	(61)		(88)
Comprehensive loss	(12,107)	(7,847)	(23,074)	(13,576)
Partnership revenue
Revenue:
Revenue	728	229	1,747	945
Product revenue
Revenue:
Revenue	$ 187	$ 172	$ 332	$ 322